ABBV: Abbvie Inc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 241,407.76
Enterprise Value ($M) 297,186.76
Book Value ($M) 17,287.00
Book Value / Share 9.80
Price / Book 13.96
NCAV ($M) -94,753.00
NCAV / Share -53.71
Price / NCAV -2.55

Profitability (mra)
Return on Invested Capital (ROIC) 0.09
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.49

Liquidity (mrq)
Quick Ratio 0.82
Current Ratio 0.96

Balance Sheet (mrq) ($M)
Current Assets 26,488.00
Assets 134,544.00
Liabilities 121,241.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 58,054.00
Operating Income 22,671.00
Net Income 11,836.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 24,943.00
Cash from Investing -623.00
Cash from Financing -24,803.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-16 13G/A BlackRock Inc. 7.80 8.19
02-09 13G/A Vanguard Group Inc 8.95 8.21

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-02-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
2022-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2022-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-06-02 697,915 6,661,613 10.48
2023-06-01 1,316,144 11,895,561 11.06
2023-05-31 692,007 12,579,059 5.50
2023-05-30 675,069 7,671,512 8.80

(click for more detail)

Similar Companies
ABT – Abbott Laboratories ADCT – Adc Therapeutics SA


Financial data and stock pages provided by
Fintel.io